iBio (NYSEMKT:IBIO) Trading 1.7% Higher – Here’s What Happened

iBio, Inc. (NYSEMKT:IBIO)’s share price was up 1.7% during trading on Monday . The stock traded as high as $2.39 and last traded at $2.35. Approximately 40,857 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 113,212 shares. The stock had previously closed at $2.31.

iBio Stock Up 1.7 %

The company has a 50 day moving average of $2.63 and a 200 day moving average of $2.27. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.91 and a quick ratio of 0.91.

iBio Company Profile

iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.